Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 3989286, 11 pages
http://dx.doi.org/10.1155/2016/3989286
Research Article

Cancer Related Fatigue and Quality of Life in Patients with Advanced Prostate Cancer Undergoing Chemotherapy

1Cyprus University of Technology, 15th Vragadinou Street, 3041 Limassol, Cyprus
2University of Turku, 20014 Turku, Finland

Received 3 November 2015; Accepted 17 January 2016

Academic Editor: Nick Kontodimopoulos

Copyright © 2016 Andreas Charalambous and Christiana Kouta. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. M. Gjerset, S. D. Fosså, A. A. Dahl, J. H. Loge, T. Ensby, and L. Thorsen, “Effects of a 1-week inpatient course including information, physical activity, and group sessions for prostate cancer patients,” Journal of Cancer Education, vol. 26, no. 4, pp. 754–760, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. D. P. Braun, D. Gupta, and E. D. Staren, “Predicting survival in prostate cancer: the role of quality of life assessment,” Supportive Care in Cancer, vol. 20, no. 6, pp. 1267–1274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent et al., “Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012,” European Journal of Cancer, vol. 49, no. 6, pp. 1374–1403, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. S. D. Lambert, A. Girgis, J. Turner, P. McElduff, K. Kayser, and P. Vallentine, “A pilot randomized controlled trial of the feasibility of a self-directed coping skills intervention for couples facing prostate cancer: rationale and design,” Health and Quality of Life Outcomes, vol. 10, article 119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Hofman, J. L. Ryan, C. D. Figueroa-Moseley, P. Jean-Pierre, and G. R. Morrow, “Cancer-related fatigue: the scale of the problem,” The Oncologist, vol. 12, no. 1, pp. 4–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Mock, A. Atkinson, A. Barsevick et al., “NCCN practice guidelines for cancer-related fatigue,” Oncology, vol. 14, no. 11, pp. 151–161, 2000. View at Google Scholar · View at Scopus
  7. J. E. Bower, “Fatigue in cancer patients and survivors: mechanisms and treatment,” Primary Psychiatry, vol. 12, no. 5, pp. 53–57, 2005. View at Google Scholar · View at Scopus
  8. G. A. Curt, W. Breitbart, D. Cella et al., “Impact of cancer-related fatigue on the lives of patients: new findings from the fatigue coalition,” The Oncologist, vol. 5, no. 5, pp. 353–360, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Dash, K. Demas, S. Uhm et al., “Low incidence of fatigue after hypofractionated stereotactic body radiation therapy for localized prostate cancer,” Frontiers in Oncology, vol. 2, article 142, 6 pages, 2012. View at Publisher · View at Google Scholar
  10. S. Kotwal and P. Whelan, “Does failure of single hormone therapy delineate hormone refractoriness for prostate cancer?” Scandinavian Journal of Urology and Nephrology, vol. 42, no. 2, pp. 116–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Sartor, E. Flood, K. Beusterien et al., “Health-related quality of life in advanced prostate cancer and its treatments: biochemical failure and metastatic disease populations,” Clinical Genitourinary Cancer, vol. 13, no. 2, pp. 101–112, 2015. View at Publisher · View at Google Scholar
  12. J. Y. Bruce, J. M. Lang, D. G. McNeel, and G. Liu, “Current controversies in the management of biochemical failure in prostate cancer,” Clinical Advances in Hematology & Oncology, vol. 10, no. 11, pp. 716–722, 2012. View at Google Scholar
  13. M. E. Charlson, P. Pompei, K. L. Ales, and C. R. MacKenzie, “A new method of classifying prognostic comorbidity in longitudinal studies: development and validation,” Journal of Chronic Diseases, vol. 40, no. 5, pp. 373–383, 1987. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Okuyama, K. Tanaka, T. Akechi et al., “Fatigue in ambulatory patients with advanced lung cancer: prevalence, correlated factors, and screening,” Journal of Pain and Symptom Management, vol. 22, no. 1, pp. 554–564, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Okuyama, T. Akechi, A. Kugaya et al., “Development and validation of the cancer fatigue scale: a brief, three- dimensional, self-rating scale for assessment of fatigue in cancer patients,” Journal of Pain and Symptom Management, vol. 19, no. 1, pp. 5–14, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kröz, R. Zerm, M. Reif et al., “Validation of the German version of the Cancer Fatigue Scale (CFS-D),” European Journal of Cancer Care, vol. 17, no. 1, pp. 33–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. D. E. Beaton, C. Bombardier, F. Guillemin, and M. B. Ferraz, “Guidelines for the process of cross-cultural adaptation of self-report measures,” Spine, vol. 25, no. 24, pp. 3186–3191, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. P. M. Fayers, N. K. Aaronson, K. Bjordal, M. Groenvold, D. Curran, and A. Bottomley, The EORTC QLQ-C3O Scoring Manual, European Organization for Research and Treatment of Cancer, Brussels, Belgium, 3rd edition, 2001.
  19. N. Kontodimopoulos, K. Ntinoulis, and D. Niakas, “Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients,” European Journal of Cancer Care, vol. 20, no. 3, pp. 354–361, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Kontodimopoulos, A. Samartzis, A. A. Papadopoulos, and D. Niakas, “Reliability and validity of the greek QLQ-C30 and QLQ-MY20 for measuring quality of life in patients with multiple myeloma,” The Scientific World Journal, vol. 2012, Article ID 842867, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. World Medical Association Ethics Unit, Declaration of Helsinki, January 2015, http://www.wma.net/en/30publications/10policies/b3.
  22. J. Lathlean, “Qualitative analysis,” in The Research Process in Nursing, K. Gerrish and A. Lacy, Eds., pp. 417–433, Blackwell Science, Oxford, UK, 2006. View at Google Scholar
  23. M. Tavakol and R. Dennick, “Making sense of Chronbach's alpha,” International Journal of Medical Education, vol. 2, pp. 53–55, 2011. View at Google Scholar
  24. T. Okuyama, T. Akechi, Y. Shima et al., “Factors correlated with fatigue in terminally ill cancer patients: a longitudinal study,” Journal of Pain and Symptom Management, vol. 35, no. 5, pp. 515–523, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. L. Walker, “The use of saturation in qualitative research,” Canadian Journal of Cardiovascular Nursing, vol. 22, no. 2, pp. 37–46, 2012. View at Google Scholar · View at Scopus
  26. G. Guest, A. Bunce, and L. Johnson, “How many interviews are enough? An experiment with data saturation and variability,” Field Methods, vol. 18, no. 1, pp. 59–82, 2006. View at Publisher · View at Google Scholar
  27. P. Stone, M. Richards, R. A'Hern, and J. Hardy, “A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer,” Annals of Oncology, vol. 11, no. 5, pp. 561–567, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. M. P. O. Campos, B. J. Hassan, R. Riechelmann, and A. Del Giglio, “Cancer-related fatigue: a practical review,” Annals of Oncology, vol. 22, no. 6, pp. 1273–1279, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Stone, J. Hardy, K. Broadley, A. J. Tookman, A. Kurowska, and R. A'Hern, “Fatigue in advanced cancer: a prospective controlled cross-sectional study,” British Journal of Cancer, vol. 79, no. 9-10, pp. 1479–1486, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. L. A. A. Gilliam and K. S. C. Daret, “Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress,” Antioxidants and Redox Signaling, vol. 15, no. 9, pp. 2543–2563, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. L. E. Carlson, M. Angen, J. Cullum et al., “High levels of untreated distress and fatigue in cancer patients,” British Journal of Cancer, vol. 90, no. 12, pp. 2297–2304, 2004. View at Google Scholar · View at Scopus
  32. T. Mallinson, D. Cella, J. Cashy, and B. Holzner, “Giving meaning to measure: linking self-reported fatigue and function to performance of everyday activities,” Journal of Pain and Symptom Management, vol. 31, no. 3, pp. 229–241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Northouse, A.-L. Williams, B. Given, R. McCorkle, and F. H. Netter, “Psychosocial care for family caregivers of patients with cancer,” Journal of Clinical Oncology, vol. 30, no. 11, pp. 1227–1234, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. C. N. Sternberg, A. Molina, S. North et al., “Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy,” Annals of Oncology, vol. 24, no. 4, pp. 1017–1025, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. J. E. Bower, K. Bak, A. Berger et al., “Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation,” Journal of Clinical Oncology, vol. 32, no. 17, pp. 1840–1850, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Servaes, S. Verhagen, and G. Bleijenberg, “Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study,” Annals of Oncology, vol. 13, no. 4, pp. 589–598, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. L. F. Brown and K. Kroenke, “Cancer-related fatigue and its associations with depression and anxiety: a systematic review,” Psychosomatics, vol. 50, no. 5, pp. 440–447, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Ahlberg, T. Ekman, F. Gaston-Johansson, and V. Mock, “Assessment and management of cancer-related fatigue in adults,” The Lancet, vol. 362, no. 9384, pp. 640–650, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Charalabopoulos, C. Golias, A. Charalabopoulos, X. Giannakopoulos, and A. Batistatou, “Quality of life in patients suffering from prostate adenocarcinoma: a global approach,” Hippokratia, vol. 9, pp. 7–16, 2005. View at Google Scholar
  40. G. R. Morrow, “Cancer-related fatigue: causes, consequences, and management,” The Oncologist, vol. 12, no. 1, pp. 1–3, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. M. G. Sanda, R. L. Dunn, J. Michalski et al., “Quality of life and satisfaction with outcome among prostate-cancer survivors,” The New England Journal of Medicine, vol. 358, no. 12, pp. 1250–1261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Johansson, G. Steineck, L. Holmberg et al., “Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial,” The Lancet Oncology, vol. 12, no. 9, pp. 891–899, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. M. J. Resnick, D. A. Barocas, A. K. Morgans et al., “Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: defining the population at risk for harms of prostate cancer treatment,” Cancer, vol. 120, no. 8, pp. 1263–1271, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. J. A. Talcott, “Prostate cancer quality of life: beyond initial treatment- and the Patient,” Journal of Clinical Oncology, vol. 25, no. 27, pp. 4155–4156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. S. L. Maliski, L. Kwan, D. Elashoff, and M. S. Litwin, “Symptom clusters related to treatment for prostate cancer,” Oncology Nursing Forum, vol. 35, no. 5, pp. 786–793, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Charalambous, I. R. Papadopoulos, and A. Beadsmoore, “Listening to the voices of patients with cancer, their advocates and their nurses: a hermeneutic-phenomenological study of quality nursing care,” European Journal of Oncology Nursing, vol. 12, no. 5, pp. 436–442, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Olson, A. Krawchuk, and T. Quddusi, “Fatigue in individuals with advanced cancer in active treatment and palliative settings,” Cancer Nursing, vol. 30, no. 4, pp. E1–E10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Yucel, E. A. Akkaş, Y. Okur et al., “The impact of radiotherapy on quality of life for cancer patients: a longitudinal study,” Supportive Care in Cancer, vol. 22, no. 9, pp. 2479–2487, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Kawaguchi, S. Iwase, M. Koinuma et al., “Determinants affecting quality of life: implications for pharmacist counseling for patients with breast cancer in Japan,” Biological and Pharmaceutical Bulletin, vol. 35, no. 1, pp. 59–64, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. H. J. Green, K. I. Pakenham, B. C. Headley, and R. A. Gardiner, “Coping and health-related quality of life in men with prostate cancer randomly assigned to hormonal medication or close monitoring,” Psycho-Oncology, vol. 11, no. 5, pp. 401–414, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. K.-A. Phillips and J. Bernhard, “Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions,” Journal of the National Cancer Institute, vol. 95, no. 3, pp. 190–197, 2003. View at Publisher · View at Google Scholar · View at Scopus